Literature DB >> 3592364

Anthelmintic efficacy of ivermectin in naturally parasitized cats.

B L Blagburn, C M Hendrix, D S Lindsay, J L Vaughan.   

Abstract

Ivermectin was administered per os [( PO]; n = 15) or subcutaneously [( SC]; n = 3) to naturally parasitized cats at 10 (n = 6), 100 (n = 6), or 300 (n = 6) micrograms/kg of body weight. Nontreated control cats were given sterile isotonic saline solution PO (n = 5) or SC (n = 1). Qualitative fecal examinations were performed on each cat 1 day before treatment and 14 days after treatment. Cats were euthanatized 14 days after treatment, at which time parasites from the gastrointestinal tracts were recovered, identified, and enumerated. Lungs and urinary bladders were examined histologically or by digestion (lungs only) for Capillaria spp and/or Aelurostrongylus abstrusus. Ivermectin was effective in removing Ancylostoma spp at all doses, but removal of Toxocara cati required 300 micrograms of ivermectin/kg. Efficacies against A abstrusus, Capillaria spp, and Physaloptera spp could not be determined definitively. Ivermectin had no effect on Dipylidium caninum, Hydatigera taeniaeformis, Spirometra mansonoides, or Isospora spp. Adverse reactions were not observed in cats given ivermectin PO; however, 3 cats given ivermectin SC reacted as though they experienced pain at the injection site.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3592364

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  8 in total

1.  Observations on topical ivermectin in the treatment of otoacariosis, cheyletiellosis, and toxocariosis in cats.

Authors:  N Pagé; C de Jaham; M Paradis
Journal:  Can Vet J       Date:  2000-10       Impact factor: 1.008

2.  Efficacy and safety of emodepside 2.1%/praziquantel 8.6% spot-on formulation in the treatment of feline aelurostrongylosis.

Authors:  Donato Traversa; Piermarino Milillo; Angela Di Cesare; Beate Lohr; Raffaella Iorio; Fabrizio Pampurini; Roland Schaper; Roberto Bartolini; Josef Heine
Journal:  Parasitol Res       Date:  2009-08       Impact factor: 2.289

3.  Efficacy and safety of imidacloprid 10%/moxidectin 1% spot-on formulation in the treatment of feline aelurostrongylosis.

Authors:  Donato Traversa; Angela Di Cesare; Piermarino Milillo; Beate Lohr; Raffaella Iorio; Fabrizio Pampurini; Roland Schaper; Barbara Paoletti; Josef Heine
Journal:  Parasitol Res       Date:  2009-08       Impact factor: 2.289

4.  Canine and feline cardiopulmonary parasitic nematodes in Europe: emerging and underestimated.

Authors:  Donato Traversa; Angela Di Cesare; Gary Conboy
Journal:  Parasit Vectors       Date:  2010-07-23       Impact factor: 3.876

5.  Efficacy and safety of imidacloprid 10%/moxidectin 1% spot-on formulation in the treatment of feline infection by Capillaria aerophila.

Authors:  Donato Traversa; Angela Di Cesare; Emanuela Di Giulio; Giuseppe Castagna; Roland Schaper; Gabriele Braun; Beate Lohr; Fabrizio Pampurini; Piermarino Milillo; Katrin Strube
Journal:  Parasitol Res       Date:  2012-07-11       Impact factor: 2.289

6.  Occurrence and regional distribution of Aelurostrongylus abstrusus in cats in Germany.

Authors:  Dieter Barutzki; Roland Schaper
Journal:  Parasitol Res       Date:  2012-12-13       Impact factor: 2.289

Review 7.  Lower respiratory tract infections in cats: reaching beyond empirical therapy.

Authors:  Susan F Foster; Patricia Martin
Journal:  J Feline Med Surg       Date:  2011-05       Impact factor: 2.015

Review 8.  Fleas infesting pets in the era of emerging extra-intestinal nematodes.

Authors:  Donato Traversa
Journal:  Parasit Vectors       Date:  2013-03-07       Impact factor: 3.876

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.